AstraZeneca and Erin Andrews have teamed up as part of a national public health campaign to educate and empower people to Get ...

The logo of Danish ... EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy February 28, 2025 Healthcare & Pharmaceuticalscategory UK health regulator ...

UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £142.00. The ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Ionis Pharmaceuticals (IONS) announced that Ionis and AstraZeneca’s (AZN) WAINZUA eplontersen has been approved in the European Union EU for ...

The AstraZeneca PLC ADR AZN rose 1.79% to $75.57 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...

AstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists ...

In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to ...

The "Innovation Insights: Engineered Exosomes" report has been added to ResearchAndMarkets.com's offering. In the Engineered Exosome drug deals, there have been 77 deals totaling US$5.1 billion, with ...